Trulicity, Byetta, Victoza, Similar Diabetes Drugs Do Not Appear to Increase Breast Cancer Risks: Study
A new study finds no link between popular diabetes drugs like Byetta and Trulicity, and an increased risk of breast cancer.
Tag Archives: Bydureon
-
-
Invokana, Farxiga Problems Renew Concerns About Direct-to-Consumer Advertisements
Amid recent safety questions, concerns have emerged about direct-to-consumer advertisements for Invokana and similar drugs that include off-label marketing weight loss claims.
-
Byetta Settlements Reached in 84 Cases, But Hundreds of Lawsuits Remain
AstraZeneca announced it has settled 84 Byetta lawsuits, but still faces more than 400 claims involving allegations that the diabetes drug caused pancreatic cancer, thyroid cancer or pancreatitis.
-
Bydureon Side Effects Linked to Injection Site Reactions
Bydureon, a long-acting version of Byetta, has been linked to severe injection site reactions, the FDA warns.
-
AstraZeneca Buys Bristol-Myers Squibb Diabetes Interests, Byetta
AstraZeneca has agreed to buy all of Bristol-Myers Squibb's diabetes drug interests, as a growing number of Byetta, Bydureon and Ongylza lawsuits continue to be filed by former users of…
-
Pancreatic Cancer Wrongful Death Lawsuit Filed Over Diabetes Drugs
A wrongful death lawsuit has been filed by the family of a California woman, which alleges that their mother developed pancreatic cancer from side effects of the diabetes drugs Byetta,…
-
Januvia, Byetta Pancreatic Cancer Risk Review Launched by FDA
The FDA has launched an investigating into the possibility that diabetics may face an increased risk of pancreatitis and pancreatic cancer from an entire class of diabetes drugs, which includes…
-
Byetta Heart Risk Information Concealed from FDA: Memo
Recently revealed government records suggest that Amylin Pharmaceuticals may have attempted to hide information about the potential risk of heart problems from Byetta, which was a factor in the FDA’s…
-
Side Effects of Byetta, Victoza, Topic of Debate at Conference
Diabetes experts meeting in Lisbon this week are taking a close look at whether a class of long-acting diabetes drugs, including Byetta and Victoza, could be linked to an increased…
